Reinfection incidence and risk among people treated for recent hepatitis C virus infection
- 17 July 2023
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 37 (12) , 1883-1890
Abstract
Objective: Reinfection poses a challenge to hepatitis C virus (HCV) elimination. This analysis assessed incidence of, and factors associated with reinfection among people treated for recent HCV (duration of infection <12 months). Methods: Participants treated for recent HCV (primary infection or reinfection) in an international randomized trial were followed at 3-monthly intervals for up to 2 years to assess for reinfection. Reinfection incidence was calculated using person-time of observation. Factors associated with HCV reinfection were assessed using Cox proportional hazards regression analysis. Results: Of 222 participants treated for recent HCV, 196 (62% primary infection, 38% reinfection) were included in the cohort at risk for reinfection, of whom 87% identified as gay or bisexual men, 71% had HIV and 20% injected drugs in the month prior to enrolment. During 198 person-years of follow-up, 28 cases of HCV reinfection were identified among 27 participants, for an incidence of 14.2 per 100 person-years [95% confidence interval (CI) 9.8–20.5]. Reinfection was associated with prior HCV reinfection [adjusted hazards ratio (aHR) 2.42; 95% CI 1.08–5.38], injection drug use posttreatment (aHR 2.53; 95% CI 1.14–5.59), condomless anal intercourse with casual male partners (aHR 3.32; 95% CI 1.14–9.65) and geographic region (United Kingdom, aHR 0.21; 95% CI 0.06–0.75). Among gay and bisexual men (GBM), reinfection was also associated with sexualized drug use involving injecting posttreatment (aHR 2.97; 95% CI 1.10–8.02). Conclusion: High reinfection incidence following treatment for recent HCV among people with ongoing sexual and drug use risk behaviour highlights the need for posttreatment surveillance, rapid retreatment of reinfection and targeted harm reduction strategies.Keywords
This publication has 27 references indexed in Scilit:
- Hepatitis C reinfection after successful antiviral treatment among people who inject drugs: A meta-analysisJournal of Hepatology, 2020
- Moving Towards Hepatitis C Microelimination Among People Living With Human Immunodeficiency Virus in Australia: The CEASE StudyClinical Infectious Diseases, 2019
- Chemsex behaviours among men who have sex with men: A systematic review of the literatureInternational Journal of Drug Policy, 2019
- Changing the odds: motives for and barriers to reducing HCV-related sexual risk behaviour among HIV-infected MSM previously infected with HCVBMC Infectious Diseases, 2018
- Management of acute HCV infection in the era of direct-acting antiviral therapyNature Reviews Gastroenterology & Hepatology, 2018
- Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic reviewThe Lancet Global Health, 2017
- Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic reviewThe Lancet Global Health, 2017
- Needle and syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a Cochrane Review and meta‐analysisAddiction, 2017
- HCV reinfection incidence among individuals treated for recent infectionJournal of Viral Hepatitis, 2016
- The Influence of Hepatitis C Virus Genetic Region on Phylogenetic Clustering AnalysisPLOS ONE, 2015